Chinese Health Ivvestigation Of Nurse Aging | NCT01994655

Studies
Chinese Health Ivvestigation Of Nurse Aging

NCT01994655

Sponsor

Bai Wen-Pei

Status

Unknown status

Last Update Posted

Nov 26, 2013Estimated

Enrollment

2,000Estimated

Phase

Phase 1Phase 2

Conditions

Hot Flashes

Interventions

Doing exercise
Doing exercise

Countries

Not provided

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Nov 2013

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Active, not recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 2008

Primary Completion Date

Sep 2015Estimated

Completion Date

Sep 2016Estimated

First Submitted Date

Nov 20, 2013

First Submission Date that Met QC Criteria

Nov 20, 2013

First Posted Date

Nov 26, 2013Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Nov 20, 2013

Last Update Posted Date

Nov 26, 2013Estimated

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Climacteric symptoms can be treated by doing exercise,not hormone replacement therapy.

Detailed Description

Hormone replacement therapy(HRT) is the main therapy to climacteric symptoms. But HRT also has a lot of disadvantages, such as cardiovascular disease, breast cancer .In our previous investigation,we found that doing exercise is helpful for climacteric symptoms.So we want to make a detailed investigation to research it.

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Phase 1Phase 2

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

2,000Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Doing exercise	Experimental	We want to use Kupperman Index to assess the severity of climacteric symptoms,and assess the effect of doing exercise fof the climacteric symptoms	Other: Doing exercise

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Doing exercise	Other	We want to investigate the effects of exercise on climacteric symptoms	Doing exercise

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
KMI	KMI is the short of Kupperman Index,which is a questionnaire to assesses the severity of climacteric symptoms.	up to 2 years

Secondary Outcomes

Measure	Description	Time Frame
blood lipid	Blood lipid is an index to assess the effect of doing exercise.	up to 2 years

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

- Women aged 40-55 who has climacteric symptoms

Exclusion Criteria:

- Women who have serious climacteric symptoms and other diseases which could interrupt the research.

Accepts Healthy Volunteers

Sex

Female

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

40 Years

Maximum Age

55 Years

Standard Ages

Adult

Study Population

Not provided

Sampling Method

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D019584	Hot Flashes

Ancestor Terms

ID	Term
D012816	Signs and Symptoms
D013568	Pathological Conditions, Signs and Symptoms

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D015444	Exercise

Ancestor Terms

ID	Term
D009043	Motor Activity
D009068	Movement
D009142	Musculoskeletal Physiological Phenomena
D055687	Musculoskeletal and Neural Physiological Phenomena

Browse Leaves

Not provided

Browse Branches

Not provided